Vaxart, Inc. VXRT
OTC PK
| 09/30/2026 | 06/30/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -60.93% | -30.70% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -60.93% | -30.70% | |||
| Cost of Revenue | -32.37% | 14.76% | |||
| Gross Profit | -85.86% | -166.93% | |||
| SG&A Expenses | -23.16% | 42.28% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -30.86% | 18.51% | |||
| Operating Income | -31.21% | -354.63% | |||
| Income Before Tax | -29.05% | -358.54% | |||
| Income Tax Expenses | 975.86% | 0.00% | |||
| Earnings from Continuing Operations | -31.09% | -360.55% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -31.09% | -360.55% | |||
| EBIT | -31.21% | -354.63% | |||
| EBITDA | -28.80% | -297.35% | |||
| EPS Basic | -30.70% | -359.07% | |||
| Normalized Basic EPS | -28.45% | -357.78% | |||
| EPS Diluted | -30.70% | -378.50% | |||
| Normalized Diluted EPS | -28.45% | -359.70% | |||
| Average Basic Shares Outstanding | 0.40% | 0.63% | |||
| Average Diluted Shares Outstanding | 0.40% | -0.01% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||